Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin anti-Xa pharmacokinetic study in morbidly obese bariatric surgery patients
NL-OMON37098Phase 4Active, not recruiting
- Sponsor
- Rijnstate
- Start
- Mar 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of nadroparin in venous thromboembolism (VTE), sponsored by Rijnstate. Started Mar 2013; status: active, not recruiting.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON37098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37098.